Sign up to save your podcasts
Or
Share The Evolution of Statistical Programming: How AI, Open Source & Traceability are Shaping the Future | Episode 17
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Evolution of Statistical Programming: How AI, Open Source & Traceability are Shaping the Future | Episode 17
Description
Andrew York has over 30 years experience as a statistical programmer and biostatistician. From the beginning of his career as a statistician at Roche, to his current role as Clinical Data Science Vice President at Novo Nordisk, Andy has seen the industry evolve and has played a leading role in shaping best practice in the industry.
Reflecting on these experiences, in this episode Andy shares his unique perspectives on the evolution of statistical programmers. Alongside this, Tomás and Andy discuss open-source programming, where the industry would be without standards, and the need for standards that are more sympathetic to AI and automation driven processes. Andy also explains why achieving full end-to-end traceability currently poses such a challenge, and why doing so has immense benefits to changing how we program studies today.
In this conversation, we explore:
00:00 - Introduction to the Verisian Community Podcast
02:03 - The history of statistical programming and Andrew’s journey within the industry
12:19 - Where would the industry be without standards? 21:14 - Adoption of open source
36:07 - Building a computing environment
40:11 - How can traceability transform statistical programming?
52:06 - How AI will impact the future of statistical programming
01:09:25 - The changing role of a statistical programmer
1:12:14 - Rapid fire questions
About The Verisian Community Podcast
The Verisian Community Podcast brings together experts in clinical trials to exchange innovative ideas and best practices central to clinical reporting, submission and review. Aligned with Verisian's mission to accelerate the evaluation and market launch of new medical treatments, each episode features expert insights, with guests ranging from statistical programmers to medical writers, to discuss the challenges and opportunities of the latest software and technology.
Resources
Learn more about us: https://www.verisian.com/
Join the Verisian Community: https://www.verisian.com/community
Follow us on LinkedIn: https://www.linkedin.com/company/verisian/
Listen on:
Spotify: https://open.spotify.com/show/6EnSKNpv5ENwDTIElqRDxW
Apple Podcasts: https://podcasts.apple.com/us/podcast/the-verisian-community-podcast/id1719471109
View all episodes
By VerisianDescription
Andrew York has over 30 years experience as a statistical programmer and biostatistician. From the beginning of his career as a statistician at Roche, to his current role as Clinical Data Science Vice President at Novo Nordisk, Andy has seen the industry evolve and has played a leading role in shaping best practice in the industry.
Reflecting on these experiences, in this episode Andy shares his unique perspectives on the evolution of statistical programmers. Alongside this, Tomás and Andy discuss open-source programming, where the industry would be without standards, and the need for standards that are more sympathetic to AI and automation driven processes. Andy also explains why achieving full end-to-end traceability currently poses such a challenge, and why doing so has immense benefits to changing how we program studies today.
In this conversation, we explore:
00:00 - Introduction to the Verisian Community Podcast
02:03 - The history of statistical programming and Andrew’s journey within the industry
12:19 - Where would the industry be without standards? 21:14 - Adoption of open source
36:07 - Building a computing environment
40:11 - How can traceability transform statistical programming?
52:06 - How AI will impact the future of statistical programming
01:09:25 - The changing role of a statistical programmer
1:12:14 - Rapid fire questions
About The Verisian Community Podcast
The Verisian Community Podcast brings together experts in clinical trials to exchange innovative ideas and best practices central to clinical reporting, submission and review. Aligned with Verisian's mission to accelerate the evaluation and market launch of new medical treatments, each episode features expert insights, with guests ranging from statistical programmers to medical writers, to discuss the challenges and opportunities of the latest software and technology.
Resources
Learn more about us: https://www.verisian.com/
Join the Verisian Community: https://www.verisian.com/community
Follow us on LinkedIn: https://www.linkedin.com/company/verisian/
Listen on:
Spotify: https://open.spotify.com/show/6EnSKNpv5ENwDTIElqRDxW
Apple Podcasts: https://podcasts.apple.com/us/podcast/the-verisian-community-podcast/id1719471109